RTL551 Treatment Reduces Pathogenic T Cells in EAE
Author Information
Author(s): Sinha Sushmita, Miller Lisa M., Subramanian Sandhya, Burrows Gregory G., Vandenbark Arthur A., Offner Halina
Primary Institution: Oregon Health & Science University
Hypothesis
Does RTL551 treatment affect the maturation and infiltration of pathogenic T cells in experimental autoimmune encephalomyelitis (EAE)?
Conclusion
RTL551 treatment significantly reduces pathogenic T cells in the periphery and prevents their infiltration into the central nervous system during EAE.
Supporting Evidence
- RTL551 treatment significantly reduced clinical signs of EAE.
- RTL551 prevented the trafficking of pathogenic T cells from the spleen to the CNS.
- RTL551 treatment resulted in lower frequencies of CD226 and T-bet expressing CD4+ T-cells in the blood.
Takeaway
This study shows that a treatment called RTL551 helps stop bad immune cells from causing damage in a disease called EAE, which is similar to multiple sclerosis.
Methodology
C57BL/6 mice were treated with RTL551 or control treatments after EAE induction, and various immune cell populations were analyzed using flow cytometry.
Potential Biases
Potential conflicts of interest due to financial ties of authors to a related company.
Limitations
The study is limited to a mouse model and may not fully translate to human conditions.
Participant Demographics
C57BL/6 male mice, 7-8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website